BioSpace News Archive

Have you ever considered relocating for your career? If you have, you aren’t alone. According to a recent BioSpace Community Survey, 78% of life science professionals would be open to relocation for the right job opportunity.

Since reports surfaced that Martin Shkreli used a contraband cellular phone to conduct business from behind bars, the controversial biotech bad boy investor has not been heard from. And it may be because he is currently in solitary confinement.

Medigene AG announced its participation at the following upcoming networking and scientific conferences

Eisai Co., Ltd. has announced that its in-house discovered fibroblast growth factor receptor tyrosine kinase inhibitor E7090 has been granted the SAKIGAKE designation by Japan’s Ministry of Health, Labour and Welfare for the treatment of unresectable biliary tract cancer with FGFR2 gene fusion.

Panel composition is harmonized across species to allow translation of results from murine and human samples - from lab to clinic

Positive HVAD LATERALTM Study Results Also Now Published in The Journal of Heart and Lung Transplantation

The SanBio Group announced that SB623, a regenerative cell therapy that the Group is developing globally for the treatment of chronic motor deficit resulting from traumatic brain injury (TBI), has received the Sakigake Designation for innovative medical products from the Ministry of Health, Labour, and Welfare (MHLW) of Japan.

Terns Pharmaceuticals Inc. announced that Randy Halcomb, Ph.D., senior vice president of chemistry and early development, will present a corporate overview and update on the Company’s lead programs at BioCentury’s 26th Annual Future Leaders in the Biotech Industry Conference on Friday, April 12, 2018 at 2pm Eastern Time in room 404/405.

MaxCyte, the global clinical-stage cell-based medicines and life sciences company, announced the launch of the new ExPERT™ technology platform.

POXEL SA announced its cash position and revenue for the first quarter ended March 31, 2019.